NAD+ precursors (NMN & NR): what we know, what we don't, and what to ask a clinician
THE 30-SECOND ANSWER
NAD+ is a vital molecule in every cell that declines roughly 50% by middle age. Precursors like NMN and NR can raise blood NAD+ levels — that's confirmed in human trials. Whether raising levels actually slows aging or prevents disease in humans is not yet proven. The animal data is impressive; the human translation is still early.
What it is
NAD+ (nicotinamide adenine dinucleotide) is a cellular battery found in every cell of your body. Without it, cells can't generate energy, repair DNA, or coordinate basic survival tasks. You can't swallow NAD+ directly — the molecule is too large. Instead, precursors like NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are the raw materials your body converts into NAD+ inside your cells.
Why people are interested
NAD+ levels decline dramatically with age — roughly 50% by middle age. Your mitochondria need NAD+ to convert food into energy, and specialized repair proteins (sirtuins, PARPs) need it to maintain cellular health. The theory: replenish the raw materials, keep the maintenance crew working at full capacity.
What the evidence says
Oral NMN and NR successfully raise blood NAD+ levels in humans — confirmed across multiple small, high-quality trials. NR raised levels ~40% over eight weeks.
Some small studies suggest slight improvements in muscle insulin sensitivity or physical performance — but others show no difference. Results are mixed and modest.
In laboratory mice, NMN/NR improved blood vessel function, boosted mitochondrial energy, and helped muscle stem cells regenerate — genuinely impressive results.
No large, long-term human trial has shown NAD+ precursors extend lifespan or delay age-related diseases in humans. The gap between mouse results and human proof remains wide.
What we don't know yet
Whether NMN or NR is superior — both use different cellular pathways and the debate is ongoing. The optimal daily dose for healthy aging. Long-term safety data beyond a few months. Whether the impressive mouse results will translate meaningfully to humans.
Who should be careful
Short-term safety profiles are reassuring — mild stomach discomfort at high doses is the most common side effect. The major theoretical concern: NAD+ supports energy production in all rapidly dividing cells, including cancer cells. If active tumors are present, boosting NAD+ could theoretically fuel their growth. Avoid NAD+ precursors if you have active cancer unless cleared by your oncologist.
Questions worth asking a clinician
Given my personal and family medical history — especially regarding oncology — is it safe for me to try an NAD+ precursor?
Are there any known interactions between NMN/NR and my current medications or supplements?
What is a reasonable, conservative starting dose, and how long should I take it before we evaluate results?
Should we do baseline testing for metabolic health or inflammatory markers before I start?
Ready to ask these questions? EllieMD connects you with licensed providers who can answer them.
Start your free consultation →Physician-supervised programs from $299/month · Referral link
The Peptide Sourcing Checklist
Five questions your provider should be able to answer before you start any protocol. If they can't, keep looking.
Free. No spam. You'll see the guide right away — and get a copy from support@conciergewellness.ai.
Think this might be worth exploring?
EllieMD connects you with licensed U.S. providers who can evaluate what's appropriate for you. We don't prescribe or sell — they handle the medical path. Physician-supervised programs from $299/month.
Start your free consultation →Referral link · You'll leave this site for EllieMD's official platform